Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Management of Carvedilol in Patients with Heart Rate Less Than 60

Introduction to Carvedilol Management

  • The European Society of Cardiology recommends that carvedilol should generally not be held for a heart rate less than 60 bpm alone, but dose reduction should be considered if the heart rate drops below 55 bpm 1

Key Thresholds for Action

  • A heart rate of 50-60 bpm is often the therapeutic target range for beta-blocker therapy in heart failure and post-MI patients, according to the American Heart Association 2, 3

Clinical Context and Contraindications

  • The American College of Cardiology states that second- or third-degree AV block and sick sinus syndrome are absolute contraindications for carvedilol 3
  • Relative caution with bradycardia is advised in patients with marked first-degree AV block (PR interval >0.24 seconds) or sinus bradycardia with heart rate <50 bpm, as recommended by the American Heart Association 2, 3

Management Algorithm

  • If HR is 55-60 bpm, the European Society of Cardiology recommends continuing the current dose if the patient is asymptomatic, monitoring BP and ECG regularly, and assessing for signs of hypoperfusion or symptomatic bradycardia 1, 3
  • If HR is <55 bpm, the American Heart Association suggests reducing the carvedilol dose (do not discontinue) and monitoring closely for symptoms 3
  • If HR is <50 bpm or symptomatic bradycardia, the American College of Cardiology recommends holding or reducing beta-blocker temporarily, evaluating for conduction abnormalities, and considering pacemaker placement if indicated 2, 3, 4

Special Considerations

  • The American Heart Association strongly recommends beta-blockers before discharge in patients with compensated heart failure or LV systolic dysfunction for secondary prevention, even if they initially presented with decompensation 2, 3
  • In patients with heart failure and low blood pressure who also have HR <60 bpm, the European Society of Cardiology suggests considering reducing or stopping ivabradine first, reducing RAAS inhibitors before reducing beta-blockers, and replacing carvedilol with metoprolol or bisoprolol if bradycardia persists 4

Monitoring Requirements

  • When continuing carvedilol with HR <60 bpm, the European Society of Cardiology recommends monitoring BP and ECG regularly, assessing for symptoms, and checking for signs of hypoperfusion or worsening heart failure 1, 3, 5

REFERENCES